- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02289014
Web-based Stress Management for Newly Diagnosed Cancer Patients (STREAM-1) (STREAM)
Web-based Stress Management for Newly Diagnosed Cancer Patients (STREAM-1): A Randomized, Wait-list Controlled Intervention Study
Many cancer patients experience their illness as substantial psychological burden. About half of the cancer patients suffer from severe stress symptoms and around one third of the patients fulfill the criteria for a clinically relevant psychological disorder (mainly anxiety disorder and/or major depression). Studies show, that a high level of distress in cancer patients is associated with more side effects of and a reduced compliance for oncological treatment.
Today, the efficacy of psycho-oncological interventions is well studied and proven. Besides the reduction of levels of anxiety, distress and depression, psycho-oncological support facilitates dealing with physical complaints and increases quality of life. Yet, psycho-oncological support is rarely utilized by male patients and insufficiently accessible for many patients (i.a. lack of supply in the respective area, cost issues).
The internet overcomes some of these barriers, as it can be used independently of time and location. Internet-based therapies are therefore a growing field of interest in research and there is evidence for treatment efficacy for several psychological disorders. Moreover effect sizes of traditional face-to-face and interactive web-based interventions are comparable. However, web-based interventions for cancer patients are still scarce. The present research project therefore develops a comprehensive stress management program accessible for a vast number of cancer patients. The study targets primarily to evaluate the feasibility of the program (technical, organizational feasibility, accessibility). In addition, the preliminary efficacy of the program will be analyzed in order to adapt future programs for specific patient groups.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The present study is designed as a randomized controlled wait-list intervention study. Within 12 weeks of the start of anti-cancer treatment, patients will be randomly assigned to the web-based stress management intervention or a wait-list control condition.
Inclusion criteria:
Patients with any kind of newly diagnosed cancer undergoing first Treatment regardless of the Setting. Patients undergoing first treatment for newly diagnosed relapse of cancer, who have received prior curatively-intended Treatment.
Inclusion is allowed immediately prior to or within 12 weeks of the start of treatment. If surgery was performed initially and is followed by systemic treatment or radiotherapy, start of systemic treatment or radiotherapy is counted as first treatment. Prior treatment -including chemotherapy- for a different, prior malignant tumor is allowed. Concomitant participation in an experimental therapeutic drug trial is allowed. Age >18 years. Command of the German language. Internet access and basic computer skills. Life expectancy of >6 months.
Exclusion criteria:
Patients undergoing second- or further line treatment. Patients treated with surgery only. Patients participating in a concomitant psychological intervention trial
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Basel, Switzerland, 4031
- University Hospital Basel
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with any kind of newly diagnosed cancer undergoing first treatment (including radiotherapy, hormonal treatment, targeted therapies, chemotherapy or combined-modality treatment) regardless of the setting (adjuvant treatment, curative treatment, palliative first-line treatment)
- Patients with newly diagnosed relapse of cancer, who had received prior curatively-intended treatment
- Inclusion is allowed immediately prior to or within 12 weeks of the start of treatment
- Patients must have cytologically or histologically proven diagnosis of malignant disease (either at diagnosis or at relapse)
- Prior treatment -including chemotherapy- for a different, prior malignant tumor is allowed
- Concomitant participation in an experimental therapeutic drug trial is allowed
- Age >18 years
- Command of the German language
- Internet access and basic computer skills
- Life expectancy of >6 months
Exclusion Criteria:
- Patients undergoing palliative second- or further line chemotherapy treatment
- Patients treated with surgery only
- Patients participating in a concomitant psychological intervention trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Wait-list control group
|
|
EXPERIMENTAL: Active treatment group
online stress Management program
|
Active treatment group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dropout rate during the internet-based recruitment procedure
Time Frame: Measures assessed at time point of recruitment
|
Measures assessed at time point of recruitment
|
|
Characteristics (Sociodemographic and medical history; i.e. age, gender, education, cancer diagnosis and cancer treatment) of the population willing to participate in an online stress management program shortly after diagnosis of cancer
Time Frame: Measures assessed at time point of recruitment
|
Measures assessed at time point of recruitment
|
|
Number of participants who completed at least 6 out of 8 modules, i.e. 75 % of each module
Time Frame: participants will be followed for the duration of the intervention, an expected average of 8 weeks
|
participants will be followed for the duration of the intervention, an expected average of 8 weeks
|
|
Working Alliance scores on the Working Alliance (WAI) Questionnaire
Time Frame: participants will be followed for the duration of the intervention, an expected average of 8 weeks
|
participants will be followed for the duration of the intervention, an expected average of 8 weeks
|
|
Usability scores on the System Usability Scale (SUS)
Time Frame: participants will be followed for the duration of the intervention, an expected average of 8 weeks
|
participants will be followed for the duration of the intervention, an expected average of 8 weeks
|
|
Client satisfaction on the Client Satisfaction Questionnaire-8 (CSQ-8)
Time Frame: Measures assessed after 8 weeks
|
German Version of the Client Satisfaction Questionnaire: Fragebogen zur Messung der Patientenzufriedenheit (ZUF-8) will be used
|
Measures assessed after 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Psychological distress on the Distress Thermometer (visual analogue scale)
Time Frame: Change measures (e.g., "baseline, 8 weeks")
|
Change measures (e.g., "baseline, 8 weeks")
|
|
Anxiety and Depression scores on the Hospital Anxiety and Depression Scale (HADS)
Time Frame: Change measures (e.g., "baseline, 8 weeks")
|
Change measures (e.g., "baseline, 8 weeks")
|
|
Quality of life and fatigue scores on the Functional Assessment in Cancer Therapy-Fatigue (FACT-F)
Time Frame: hange measures (e.g., "baseline, 8 weeks")
|
hange measures (e.g., "baseline, 8 weeks")
|
|
Avoidance and psychological inflexibility scores on the Acceptance and Action questionnaire (AAQ)
Time Frame: ange measures (e.g., "baseline, 8 weeks")
|
German Version of the Acceptance and Action questionnaire: Fragebogen zur Akzeptanz und Handeln (FAH II) will be used
|
ange measures (e.g., "baseline, 8 weeks")
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Urech C, Grossert A, Alder J, Scherer S, Handschin B, Kasenda B, Borislavova B, Degen S, Erb J, Faessler A, Gattlen L, Schibli S, Werndli C, Gaab J, Berger T, Zumbrunn T, Hess V. Web-Based Stress Management for Newly Diagnosed Patients With Cancer (STREAM): A Randomized, Wait-List Controlled Intervention Study. J Clin Oncol. 2018 Mar 10;36(8):780-788. doi: 10.1200/JCO.2017.74.8491. Epub 2018 Jan 25.
- Grossert A, Urech C, Alder J, Gaab J, Berger T, Hess V. Web-based stress management for newly diagnosed cancer patients (STREAM-1): a randomized, wait-list controlled intervention study. BMC Cancer. 2016 Nov 3;16(1):838. doi: 10.1186/s12885-016-2866-0.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- KFS-3260-08-2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
Clinical Trials on online stress Management program
-
Rigshospitalet, DenmarkThe Novo Nordic FoundationNot yet recruitingChronic Non-Cancer Pain
-
St. Mary's Research Center, CanadaMcGill UniversityCompletedCardiovascular Diseases | Stress, PsychologicalCanada
-
Erasmus Medical CenterIndigo Rijnmond, the Netherlands; Avant Sanare, The Netherlands; Erasmus University...UnknownSmoking | Smoking Cessation | Stress | Stress, Psychological | Health Behavior | Smoking, Tobacco | Smoking, CigaretteNetherlands
-
Boston IVFWithdrawnInfertilityUnited States
-
Massachusetts General HospitalUnited States Department of DefenseRecruiting
-
Mclean HospitalMassachusetts General HospitalCompleted
-
Universiti Putra MalaysiaCompletedOccupational Stress | Coping SkillsJordan
-
University of GujratCompleted
-
Massachusetts General HospitalRecruitingNeurofibromatoses | Neurofibromatosis 1 | Neurofibromatosis 2 | SchwannomatosisUnited States
-
Ottawa Hospital Research InstituteNot yet recruitingQuality of Life | Chronic PainCanada